首页> 美国卫生研究院文献>American Journal of Clinical and Experimental Immunology >Treatment of multiple system atrophy - the past present and future
【2h】

Treatment of multiple system atrophy - the past present and future

机译:多系统萎缩的治疗-过去现在和未来

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Multiple system atrophy is a sporadic progressive degenerative disease which is characterized by multiple central nervous systems involved. So far, there is no effective medicine to cure MSA. The main research direction of treatment includes immunization transplantation and cytotherapy. Human umbilical cord blood is the residue of blood in the placenta and umbilical cord after fetal delivery. It is the most abundant cell bank and its usage is not limited to treat hematological diseases. The researches about hUCB-MNC treatment on MSA are increasing gradually. The potential of other MSC is also discussed. Lateral atlanto-occipital space puncture is an ingenious way created by Professor Dianrong Gong. More than 30 cases of MSA have been treated by this method with fine clinical effect and without serious complications. It indicates that stem cells treatment is a valid method for refractory nerve system diseases.
机译:多系统萎缩是一种偶发性进行性退行性疾病,其特征是涉及多个中枢神经系统。到目前为止,还没有有效的药物可以治愈MSA。治疗的主要研究方向包括免疫移植和细胞疗法。人脐带血是胎儿分娩后胎盘和脐带中血液的残留物。它是最丰富的细胞库,其用途不限于治疗血液病。 hUCB-MNC治疗MSA的研究逐渐增多。还讨论了其他MSC的潜力。寰枕外侧穿刺是龚殿荣教授创造的一种巧妙方法。该方法治疗MSA 30余例,临床效果良好,无严重并发症。这表明干细胞治疗是治疗难治性神经系统疾病的有效方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号